Concepedia

Paul E Irving

PE

8

Publications

304

Citations

8

H-Index

1991

Active since

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

Paul E Irving is an author at Research Triangle Park Foundation specializing in alpha-adrenergic pharmacology, molecular pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1991–2003

8

Publications

8

The Use of Stimulus-Biased Assay Systems to Detect Agonist-Specific Receptor Active States: Implications for the Trafficking of Receptor Stimulus by Agonists

Chris Watson, Grace Chen, Paul E Irving et al. · Molecular Pharmacology · 2000 · 102 citations

Expression Cloning and Receptor Pharmacology of Human Calcitonin Receptors from MCF-7 Cells and Their Relationship to Amylin Receptors

Wen-Ji Chen, Susan Armour, James M. Way et al. · Molecular Pharmacology · 1997 · 78 citations

The relative efficiency of beta adrenoceptor coupling to myocardial inotropy and diastolic relaxation: organ-selective treatment for diastolic dysfunction.

Terry Kenakin, Jayaseelan Ambrose, Paul E Irving · Journal of Pharmacology and Experimental Therapeutics · 1991 · 40 citations

2-(Anilinomethyl)imidazolines as α<sub>1</sub> Adrenergic Receptor Agonists:  the Discovery of α<sub>1</sub><sub>a</sub> Subtype Selective 2‘-Alkylsulfonyl-Substituted Analogues

Stephen J. Hodson, Michael J. Bishop, Jason D. Speake et al. · Journal of Medicinal Chemistry · 2002 · 25 citations · Full text

, , +13

α1-Adrenoceptor Agonists: The Identification of Novel α1A Subtype Selective 2′-Heteroaryl-2-(phenoxymethyl)imidazolines

Michael J. Bishop, Kevin A Barvian, Judd Berman et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 19 citations · Full text

, , +8

Rows per page

1–5 of 8